Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

Similar articles for PubMed (Select 25084205)

1.

Methodological issues in the development of a pharmacogenomic algorithm for warfarin dosing: comparison of two regression approaches.

Pavani A, Naushad SM, Uma A, Kutala VK.

Pharmacogenomics. 2014 Jun;15(8):1125-32. doi: 10.2217/pgs.14.59.

PMID:
25084205
2.

To the Editor: Clinical utility of warfarin pharmacogenomics.

Smith DM, Cristiani C, Teng KA, Hicks JK.

Cleve Clin J Med. 2015 May;82(5):268-9. doi: 10.3949/ccjm.82c.05001. No abstract available.

3.

Comparison of the predictive abilities of pharmacogenetics-based warfarin dosing algorithms using seven mathematical models in Chinese patients.

Li X, Liu R, Luo ZY, Yan H, Huang WH, Yin JY, Mao XY, Chen XP, Liu ZQ, Zhou HH, Zhang W.

Pharmacogenomics. 2015;16(6):583-90. doi: 10.2217/pgs.15.26. Epub 2015 Apr 15.

PMID:
25872772
4.

Pharmacogenomic testing and response to warfarin.

Wu AH.

Lancet. 2015 Jun 6;385(9984):2231-2. doi: 10.1016/S0140-6736(14)62219-4. Epub 2015 Mar 11. No abstract available.

PMID:
25769360
5.

A review of a priori regression models for warfarin maintenance dose prediction.

Francis B, Lane S, Pirmohamed M, Jorgensen A.

PLoS One. 2014 Dec 12;9(12):e114896. doi: 10.1371/journal.pone.0114896. eCollection 2014.

6.

[Establishment and preliminary validation of warfarin maintenance dose algorithm in Chinese Han Population].

Lou Y, Hua L, Han L, Li Y, Zhang X, Tang M, Yu H, Liu Z, Wang W, Xu J, Liu H, Li Y.

Zhonghua Xin Xue Guan Bing Za Zhi. 2014 May;42(5):384-8. Chinese.

PMID:
25042915
7.

Verification of pharmacogenetics-based warfarin dosing algorithms in Han-Chinese patients undertaking mechanic heart valve replacement.

Zhao L, Chen C, Li B, Dong L, Guo Y, Xiao X, Zhang E, Qin L.

PLoS One. 2014 Apr 11;9(4):e94573. doi: 10.1371/journal.pone.0094573. eCollection 2014.

8.

Dosage individualization of warfarin using artificial neural networks.

Saleh MI, Alzubiedi S.

Mol Diagn Ther. 2014 Jun;18(3):371-9. doi: 10.1007/s40291-014-0090-7.

PMID:
24574079
9.

Pharmacogenetics-based warfarin dosing in children.

Hamberg AK, Wadelius M.

Pharmacogenomics. 2014 Feb;15(3):361-74. doi: 10.2217/pgs.14.8. Review.

10.

A pharmacogenetic versus a clinical algorithm for warfarin dosing.

Kimmel SE, French B, Kasner SE, Johnson JA, Anderson JL, Gage BF, Rosenberg YD, Eby CS, Madigan RA, McBane RB, Abdel-Rahman SZ, Stevens SM, Yale S, Mohler ER 3rd, Fang MC, Shah V, Horenstein RB, Limdi NA, Muldowney JA 3rd, Gujral J, Delafontaine P, Desnick RJ, Ortel TL, Billett HH, Pendleton RC, Geller NL, Halperin JL, Goldhaber SZ, Caldwell MD, Califf RM, Ellenberg JH; COAG Investigators.

N Engl J Med. 2013 Dec 12;369(24):2283-93. doi: 10.1056/NEJMoa1310669. Epub 2013 Nov 19.

11.

Is there a role for MDR1, EPHX1 and protein Z gene variants in modulation of warfarin dosage? a study on a cohort of the Egyptian population.

Issac MS, El-Nahid MS, Wissa MY.

Mol Diagn Ther. 2014 Feb;18(1):73-83. doi: 10.1007/s40291-013-0055-2.

PMID:
24092646
12.

Cost-effectiveness of pharmacogenetics-guided warfarin therapy vs. alternative anticoagulation in atrial fibrillation.

Pink J, Pirmohamed M, Lane S, Hughes DA.

Clin Pharmacol Ther. 2014 Feb;95(2):199-207. doi: 10.1038/clpt.2013.190. Epub 2013 Sep 23.

PMID:
24067746
13.

Warfarin anticoagulant therapy: a Southern Italy pharmacogenetics-based dosing model.

Mazzaccara C, Conti V, Liguori R, Simeon V, Toriello M, Severini A, Perricone C, Meccariello A, Meccariello P, Vitale DF, Filippelli A, Sacchetti L.

PLoS One. 2013 Aug 26;8(8):e71505. doi: 10.1371/journal.pone.0071505. eCollection 2013.

14.

Validation of a proposed warfarin dosing algorithm based on the genetic make-up of Egyptian patients.

Ekladious SM, Issac MS, El-Atty Sharaf SA, Abou-Youssef HS.

Mol Diagn Ther. 2013 Dec;17(6):381-90. doi: 10.1007/s40291-013-0046-3.

PMID:
23839801
15.

Warfarin pharmacogenomics in children.

Vear SI, Stein CM, Ho RH.

Pediatr Blood Cancer. 2013 Sep;60(9):1402-7. doi: 10.1002/pbc.24592. Epub 2013 May 16.

16.

Does CALU SNP rs1043550 contribute variability to therapeutic warfarin dosing requirements?

Glurich I, Berg RL, Burmester JK.

Clin Med Res. 2013 Jun;11(2):73-9. doi: 10.3121/cmr.2013.1130. Epub 2013 May 8.

17.

Warfarin dose prediction in children using pharmacometric bridging--comparison with published pharmacogenetic dosing algorithms.

Hamberg AK, Friberg LE, Hanséus K, Ekman-Joelsson BM, Sunnegårdh J, Jonzon A, Lundell B, Jonsson EN, Wadelius M.

Eur J Clin Pharmacol. 2013 Jun;69(6):1275-83. doi: 10.1007/s00228-012-1466-4. Epub 2013 Jan 11. Erratum in: Eur J Clin Pharmacol. 2013 Sep;69(9):1737.

18.

Development of a pharmacogenetic-guided warfarin dosing algorithm for Puerto Rican patients.

Ramos AS, Seip RL, Rivera-Miranda G, Felici-Giovanini ME, Garcia-Berdecia R, Alejandro-Cowan Y, Kocherla M, Cruz I, Feliu JF, Cadilla CL, Renta JY, Gorowski K, Vergara C, Ruaño G, Duconge J.

Pharmacogenomics. 2012 Dec;13(16):1937-50. doi: 10.2217/pgs.12.171.

19.

Development and comparison of a new personalized warfarin stable dose prediction algorithm in Chinese patients undergoing heart valve replacement.

Tan SL, Li Z, Song GB, Liu LM, Zhang W, Peng J, Zhang T, Jia FF, Zhou G, Zhou HH, Zhou XM.

Pharmazie. 2012 Nov;67(11):930-7.

PMID:
23210243
20.

Creating a genotype-based dosing algorithm for acenocoumarol steady dose.

Cerezo-Manchado JJ, Rosafalco M, Antón AI, Pérez-Andreu V, Garcia-Barberá N, Martinez AB, Corral J, Vicente V, González-Conejero R, Roldán V.

Thromb Haemost. 2013 Jan;109(1):146-53. doi: 10.1160/TH12-08-0631. Epub 2012 Nov 29.

PMID:
23196355
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk